88 related articles for article (PubMed ID: 6548630)
1. Modulation by a human interferon of antitumor effects of cyclophosphamide against a lymphosarcoma in hamsters.
Lee SH; Chiu H; Renton KW; Stebbing N
Biochem Pharmacol; 1984 Nov; 33(21):3439-43. PubMed ID: 6548630
[TBL] [Abstract][Full Text] [Related]
2. Antiviral and antitumor effects of a human interferon analog, IFN-alpha Con 1, assessed in hamsters.
Altrock BW; Fagin KD; Hockman HR; Fish EN; Goldstein L; Chang D; Duker K; Stebbing N
J Interferon Res; 1986 Aug; 6(4):405-15. PubMed ID: 3021874
[TBL] [Abstract][Full Text] [Related]
3. Induction and depression of cytochrome P-450-dependent mixed-function oxidase by a cloned consensus alpha-interferon (IFN-alpha CON1) in the hamster.
Moochhala SM; Renton KW; Stebbing N
Biochem Pharmacol; 1989 Feb; 38(3):439-47. PubMed ID: 2917006
[TBL] [Abstract][Full Text] [Related]
4. Antiherpetic effects of a human alpha interferon analog, IFN-alpha Con1, in hamsters.
Fish EN; Banerjee K; Levine HL; Stebbing N
Antimicrob Agents Chemother; 1986 Jul; 30(1):52-6. PubMed ID: 3019238
[TBL] [Abstract][Full Text] [Related]
5. [Apoptosis-inducing and anti-tumor effect of cyclophosphamide, cisplatin and adriamycin used separately or combined in murine lymphosarcoma LS].
Nikolin VP; Kaledin VI; Baĭmak TIu; Galiamova MR; Popova NA; Voĭtsitskiĭ VE
Vopr Onkol; 2002; 48(2):211-5. PubMed ID: 12227071
[TBL] [Abstract][Full Text] [Related]
6. [A preliminary study of chemo-interferon therapy in malignant lymphoma].
Takeyama H; Yano K; Fukutani H; Watanabe E
Gan To Kagaku Ryoho; 1987 Jan; 14(1):140-5. PubMed ID: 3800402
[TBL] [Abstract][Full Text] [Related]
7. Effect of interferon-alpha (IFN alpha) on various human tumor xenografts.
Nagy P; Kopper L; Gyapay G; Péterfy F; Lapis K
Anticancer Res; 1988; 8(3):467-9. PubMed ID: 3389749
[TBL] [Abstract][Full Text] [Related]
8. Current and future uses of recombinant interferon alpha in the treatment of low-grade non-Hodgkin's lymphoma.
Steis RG; Foon KA; Longo DL
Cancer; 1987 Feb; 59(3 Suppl):658-63. PubMed ID: 10822466
[TBL] [Abstract][Full Text] [Related]
9. Comparison of transforming, antimitotic and chromosomal aberration-inducing properties of melphalan and cyclophosphamide.
Chłopkiewicz B; Anuszewska E
Pol J Pharmacol Pharm; 1989; 41(4):293-8. PubMed ID: 2634828
[TBL] [Abstract][Full Text] [Related]
10. Interferon alfa-2b-cyclophosphamide combination studies: in vitro and phase I-II clinical results.
Durie BG; Clouse L; Braich T; Grimm M; Robertone AB
Semin Oncol; 1986 Sep; 13(3 Suppl 2):84-8. PubMed ID: 3764444
[TBL] [Abstract][Full Text] [Related]
11. [Activity and induction of CYP2B, CYP2C, and CYP3A in tissues of cyclophosphane-sensitive and resistant neoplasms and the liver of neoplasm-carrying mice].
Grishanov AIu; Kaledin VI; Zueva TV; Nekhoroshkova EK; Nikolin VP; Liakhovich VV
Biomed Khim; 2003; 49(1):27-34. PubMed ID: 14569871
[TBL] [Abstract][Full Text] [Related]
12. [Cyclophosphamide-induced apoptosis of murine lymphosarcoma cells in vivo].
Kaledin VI; Nikolin VP; Ageeva TA; Timofeeva OA; Filipenko ML; Ronichevskaia GM; Morozkova TS; Popova NA; Baĭmak TIu
Vopr Onkol; 2000; 46(5):588-93. PubMed ID: 11202193
[TBL] [Abstract][Full Text] [Related]
13. Acute in vivo resistance in high-dose therapy.
Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
[TBL] [Abstract][Full Text] [Related]
14. Synergistic interactions between cyclophosphamide or melphalan and VP-16 in a human rhabdomyosarcoma xenograft.
Lilley ER; Rosenberg MC; Elion GB; Colvin OM; Bigner DD; Friedman HS
Cancer Res; 1990 Jan; 50(2):284-7. PubMed ID: 2295068
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of changes in natural cytostatic and cytotoxic activity of mouse spleen cells after treatment with cyclophosphamide and alpha-interferon].
Van'ko LV; Bogdashin IV; Sukhikh GT; Totibadze NV; Fuks BB
Biull Eksp Biol Med; 1986 Aug; 102(8):200-3. PubMed ID: 3488771
[TBL] [Abstract][Full Text] [Related]
16. Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis.
Korolenko TA; Poteryaeva ON; Djanayeva SJ; Svechnikova IG; Kaledin VI; Timofeyeva OA; Filipenko ML; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):285-92. PubMed ID: 11345040
[TBL] [Abstract][Full Text] [Related]
17. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
Borden EC; Sidky YA; Hatcher JF; Bryan GT
Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
[TBL] [Abstract][Full Text] [Related]
18. [Antitumor effect of the Soviet recombinant alpha2-interferon (reaferon) under experimental conditions].
Lavrukhina LA; Posevaia TA; Barinskiĭ IF; Ershov FI
Vopr Virusol; 1989; 34(3):312-5. PubMed ID: 2477953
[TBL] [Abstract][Full Text] [Related]
19. A phase I trial of interferon-alpha-2a plus cyclophosphamide, vincristine, prednisone, and doxorubicin.
Schiller JH; Hawkins MJ; O'Connell MJ; Sielaff K; Borden EC
J Biol Response Mod; 1989 Jun; 8(3):252-61. PubMed ID: 2746297
[TBL] [Abstract][Full Text] [Related]
20. [Reciprocal effect of cyclophosphane on the liver cytochrome P-450 and immunity system].
Kovalev IE; Shipulina NV
Farmakol Toksikol; 1983; 46(4):71-6. PubMed ID: 6617839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
